Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
Sinovac Biotech Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2020 | 479.31M |
| September 30, 2020 | 24.66M |
| June 30, 2020 | 22.17M |
| March 31, 2020 | 29.54M |
| December 31, 2019 | 39.07M |
| September 30, 2019 | 20.32M |
| June 30, 2019 | 21.86M |
| March 31, 2019 | 4.204M |
| December 31, 2018 | 7.943M |
| September 30, 2018 | 1.813M |
| June 30, 2018 | -11.24M |
| March 31, 2018 | -9.323M |
| December 31, 2016 | -13.90M |
| September 30, 2016 | -0.635M |
| June 30, 2016 | -3.582M |
| March 31, 2016 | 2.863M |
| December 31, 2015 | 4.211M |
| September 30, 2015 | -4.599M |
| June 30, 2015 | -6.485M |
| March 31, 2015 | -12.52M |
| December 31, 2014 | -10.13M |
| September 30, 2014 | 4.11M |
| June 30, 2014 | 3.467M |
| Date | Value |
|---|---|
| March 31, 2014 | 5.346M |
| December 31, 2013 | 5.576M |
| September 30, 2013 | -6.499M |
| June 30, 2013 | -7.381M |
| March 31, 2013 | -9.954M |
| December 31, 2012 | -16.25M |
| September 30, 2012 | -7.859M |
| June 30, 2012 | 0.0354M |
| March 31, 2012 | 9.758M |
| December 31, 2011 | 13.94M |
| September 30, 2011 | 9.147M |
| June 30, 2011 | -1.541M |
| March 31, 2011 | -11.82M |
| December 31, 2010 | -14.28M |
| September 30, 2010 | 13.58M |
| June 30, 2010 | 30.09M |
| March 31, 2010 | 45.10M |
| December 31, 2009 | 48.41M |
| September 30, 2009 | 19.06M |
| June 30, 2009 | 14.91M |
| March 31, 2009 | 5.075M |
| December 31, 2008 | 10.50M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
20.32M
Minimum
Sep 2019
479.31M
Maximum
Dec 2020
90.99M
Average
24.66M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
| CASI Pharmaceuticals Inc | -- |
| Zai Lab Ltd | -198.18M |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |